J4G-MC-JZVD (FORAGER-2)

A Phase 3, Randomized, Double-blind, Placebo-controlled study of LY3866288 with Enfortumab Vedotin and Pembrolizumab in Adults with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma with an FGFR3 Genetic Alteration